Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Account holders may receive promotional notifications and exclusive offers
Heightened levels are suggested to suppress appetite and influence energy expenditure to regulate body weight
Neuron 110 , 13041317 (2022)
Contact us today to learn more about our resourcing solutions.
In 2022, the FDA added Wegovy (semaglutide), Ozempic (semaglutide) and Mounjaro (tirzepatide) to the FDA drug shortage list, followed by Zepbound (tirzepatide) in 2024
US$ 23.68
US$ 26.60
US$ 25.78
US$ 28.53
US$ 20.57
US$ 23.03
